Display options
Cite
Chatzidimitriou K, Gougoura SG, Bargiota A, et al. Normal menstrual cycle steroid hormones variation does not affect the blood levels of total adiponectin and its multimer forms. J Clin Transl Endocrinol. 2015;2(2):61-65doi: 10.1016/j.jcte.2015.03.001.
Chatzidimitriou, K., Gougoura, S. G., Bargiota, A., & Koukoulis, G. N. (2015). Normal menstrual cycle steroid hormones variation does not affect the blood levels of total adiponectin and its multimer forms. Journal of clinical & translational endocrinology, 2(2), 61-65. https://doi.org/10.1016/j.jcte.2015.03.001
Chatzidimitriou, Konstantia, et al. "Normal menstrual cycle steroid hormones variation does not affect the blood levels of total adiponectin and its multimer forms." Journal of clinical & translational endocrinology vol. 2,2 (2015): 61-65. doi: https://doi.org/10.1016/j.jcte.2015.03.001
Chatzidimitriou K, Gougoura SG, Bargiota A, Koukoulis GN. Normal menstrual cycle steroid hormones variation does not affect the blood levels of total adiponectin and its multimer forms. J Clin Transl Endocrinol. 2015 Mar 18;2(2):61-65. doi: 10.1016/j.jcte.2015.03.001. eCollection 2015 Jun. PMID: 29159111; PMCID: PMC5685044.
Copy Download .nbib Format: NLM
Share it on

J Clin Transl Endocrinol. 2015 Mar 18;2(2):61-65. doi: 10.1016/j.jcte.2015.03.001. eCollection 2015 Jun.

Normal menstrual cycle steroid hormones variation does not affect the blood levels of total adiponectin and its multimer forms.

Journal of clinical & translational endocrinology

Konstantia Chatzidimitriou, Sofia G Gougoura, Alexandra Bargiota, George N Koukoulis

Affiliations

  1. Research Laboratory, Department of Endocrinology and Metabolic Diseases, Larissa University Hospital, School of Medicine, University of Thessaly, Biopolis, Larissa 41110, Greece.

PMID: 29159111 PMCID: PMC5685044 DOI: 10.1016/j.jcte.2015.03.001

Abstract

OBJECTIVE: Plasma total adiponectin reveals a sexual dimorphism indicating that gonadal steroids may be involved in its secretion and/or metabolism. However, results from previous reports are conflicting and data regarding the influence of ovarian steroids on adiponectin's multimer forms are scarce. The objective of the study was to assess if total adiponectin and its isoforms are affected by the changes of estradiol and progesterone during the normal menstrual cycle and the association of total adiponectin and its isoforms with the gonadal steroid levels.

MATERIALS/METHODS: Quantitative determination of plasma adiponectin and its multimers was conducted in the three phases of an ovulatory cycle in 13 premenopausal women, in the follicular phase of 10 more premenopausal women, in 20 postmenopausal women and in 21 men. Moreover, serum levels of FSH, LH, prolactin, estradiol, progesterone, and testosterone, sex hormone binding globulin, glucose, and insulin were measured.

RESULTS: The circulating levels of total adiponectin and its multimers were not affected by the normal variation of estradiol and progesterone across the ovulatory menstrual cycle. In the whole number of participants, the total adiponectin and high molecular weight adiponectin levels were significantly different between genders and associated positively with age and sex hormone binding globulin levels, and negatively with testosterone and progesterone levels and the waist/hip ratio. In the multiple logistic regression analysis, after adjustment for age, gender, and sex hormone binding globulin and progesterone levels, significant predictors of total adiponectin levels were the waist/hip ratio and testosterone levels, and of high molecular weight adiponectin the testosterone levels.

CONCLUSIONS: Normal menstrual cycle ovarian steroids are not involved directly in the regulation of secretion and/or metabolism of total adiponectin and its multimers. Testosterone seems to be responsible for the adiponectin's sexual dimorphism.

Keywords: Adiponectin multimers; Androgens; BMI, body mass index; Bio-T, bioavailable testosterone; CRP, C reactive protein; E2, estradiol; Estradiol; FAI, free androgen index; FSH, follicle stimulating hormone; FT, free testosterone; FT4, free thyroxine; Gonadal steroids; HMW, high molecular weight; HOMA-R, homeostasis model assessment of insulin resistance; LH, luteinizing hormone; LMW, low molecular weight; MBP, mean blood pressure; MMW, mean molecular weight; Menstrual cycle; PCOS, polycystic ovary syndrome; SHBG, sex hormone binding globulin; TA, total adiponectin; TSH, Thyroid stimulating hormone; TT, total testosterone; Testosterone; WC, waist circumference

References

  1. J Endocrinol Invest. 2011 Dec;34(11):835-9 - PubMed
  2. J Clin Endocrinol Metab. 2005 Feb;90(2):678-88 - PubMed
  3. Biol Pharm Bull. 2013;36(4):564-73 - PubMed
  4. Clin Endocrinol (Oxf). 2006 Oct;65(4):506-13 - PubMed
  5. Eur J Endocrinol. 2012 Mar;166(3):469-76 - PubMed
  6. J Biochem. 1996 Oct;120(4):803-12 - PubMed
  7. J Cell Biol. 1999 Aug 9;146(3):609-20 - PubMed
  8. Am J Physiol Endocrinol Metab. 2001 Dec;281(6):E1172-81 - PubMed
  9. Fertil Steril. 2009 Apr;91(4):1189-94 - PubMed
  10. PLoS One. 2012;7(10):e47315 - PubMed
  11. Metabolism. 2008 Nov;57(11):1509-15 - PubMed
  12. J Androl. 2005 Jan-Feb;26(1):85-92 - PubMed
  13. Metabolism. 2005 Dec;54(12):1610-4 - PubMed
  14. Int J Obes Relat Metab Disord. 1995 Sep;19(9):614-24 - PubMed
  15. Diabetes. 2006 Jan;55(1):249-59 - PubMed
  16. J Clin Endocrinol Metab. 2001 May;86(5):1930-5 - PubMed
  17. Physiol Res. 2006;55(6):661-6 - PubMed
  18. Endocr J. 2009;56(3):425-33 - PubMed
  19. Diabetes. 2003 Feb;52(2):268-76 - PubMed
  20. Metabolism. 2011 Feb;60(2):180-5 - PubMed
  21. J Clin Endocrinol Metab. 2006 Jun;91(6):2310-6 - PubMed
  22. Atherosclerosis. 2008 Jul;199(1):123-8 - PubMed
  23. Lancet. 2002 Jul 6;360(9326):57-8 - PubMed
  24. Hum Reprod. 2003 Sep;18(9):1790-6 - PubMed
  25. Fertil Steril. 2009 Oct;92(4):1389-94 - PubMed
  26. Horm Metab Res. 2008 Nov;40(11):779-86 - PubMed
  27. Mol Cell Biol. 2007 May;27(10):3716-31 - PubMed
  28. Cytokine. 2015 Apr;72(2):130-4 - PubMed
  29. Int J Androl. 2009 Dec;32(6):616-22 - PubMed
  30. J Clin Endocrinol Metab. 2004 Aug;89(8):4053-61 - PubMed
  31. Diabetes. 2002 Sep;51(9):2734-41 - PubMed
  32. J Biol Chem. 2005 May 6;280(18):18073-80 - PubMed
  33. Clin Endocrinol (Oxf). 2004 Apr;60(4):500-7 - PubMed
  34. J Clin Endocrinol Metab. 2003 Oct;88(10):4823-31 - PubMed
  35. J Steroid Biochem Mol Biol. 2008 Apr;109(3-5):254-7 - PubMed
  36. Am J Physiol Endocrinol Metab. 2007 Jul;293(1):E42-7 - PubMed
  37. J Endocrinol Invest. 2009 Mar;32(3):279-83 - PubMed
  38. Metabolism. 2009 Feb;58(2):239-45 - PubMed

Publication Types